Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
Peer Reviewed
See detailErasmus militaire : européaniser la formation, former à l’européanisation
Paile, Sylvain ULg

in Revue Défense Nationale [=RDM] (2013), (Summer), 145-152

Detailed reference viewed: 8 (0 ULg)
Full Text
See detailErasmus van Rotterdam, Gratulatorius panegyricus ad principem Philippum archiducem austriae
Adam, Renaud ULg

in Filips de Schone (1478-1506) : schatten van de laatste hertog van Bourgondië : [tentoonstelling : Brussel, Koninklijke Bibliotheek van België, Nassaukapel, van 3 november 2006 tot 27 januari 2007] : catalogus (2006)

Detailed reference viewed: 22 (0 ULg)
Full Text
Peer Reviewed
See detailErasmus: une culture discursive mobile
Meunier, Deborah ULg

in Le discours et la langue (2012), 3.2.

Detailed reference viewed: 10 (0 ULg)
Peer Reviewed
See detailErdheim-Chester Disease : A Monocentric Series Of 96 Patients
Haroche, Julien; Arnaud, Laurent; Cohen-Aubart, Fleur et al

Poster (2013)

Detailed reference viewed: 10 (1 ULg)
Full Text
See detailErebia Ligea
Fredericq, Léon ULg

in Lambillionea (1925), (1),

Detailed reference viewed: 7 (1 ULg)
Full Text
Peer Reviewed
See detailErectile Dysfonction, a Sentinel of Cardiovascular Disease...
Andrianne, Robert ULg; Legros, Jean-Jacques ULg

in Acta Chirurgica Belgica (2010), 110

Detailed reference viewed: 18 (2 ULg)
Full Text
See detailErgonomic analysis in chronic low back pain workers
Mairiaux, Philippe ULg

Conference (2010, December 10)

Detailed reference viewed: 20 (3 ULg)
Peer Reviewed
See detailErgonomic guidelines for low back pain prevention in child care.
Somville, Pierre ULg; Mairiaux, Philippe ULg

in PROCEEDINGS IEA 2006 (2006, July)

Detailed reference viewed: 23 (2 ULg)
Peer Reviewed
See detailErgospirométrie et pratique pneumologique
Bury, Thierry ULg; Corhay, Jean-Louis ULg; Louis, Renaud ULg et al

in Revue Médicale de Liège (1993), 48(9), 523-6

Detailed reference viewed: 115 (12 ULg)
Full Text
Peer Reviewed
See detailErgot poisoning in cattle
Brihoum, M.; Desmecht, Daniel ULg; Bony, S. et al

in Annales de Médecine Vétérinaire (2004), 148(2), 97-101

In addition to the financial losses that ergot ( Claviceps purpurea) contamination causes in crops, the ingestion of ergot-contaminated food by cattle results in an intoxication that develops in several ... [more ▼]

In addition to the financial losses that ergot ( Claviceps purpurea) contamination causes in crops, the ingestion of ergot-contaminated food by cattle results in an intoxication that develops in several patterns. The observed clinical troubles may involve different systems. In this paper, we reviewed the clinical signs observed in ergot-poisoned cattle and some diagnostic and prevention aspects. [less ▲]

Detailed reference viewed: 16 (0 ULg)
Peer Reviewed
See detailErgotamine in the acute treatment of migraine: a review and European consensus.
Tfelt-Hansen, P.; Saxena, P. R.; Dahlof, C. et al

in Brain : A Journal of Neurology (2000), 123 ( Pt 1)

Ergotamine has been used in clinical practice for the acute treatment of migraine for over 50 years, but there has been little agreement on its place in clinical practice. An expert group from Europe ... [more ▼]

Ergotamine has been used in clinical practice for the acute treatment of migraine for over 50 years, but there has been little agreement on its place in clinical practice. An expert group from Europe reviewed the pre-clinical and clinical data on ergotamine as it relates to the treatment of migraine. From this review, specific suggestions for the patient groups and appropriate use of ergotamine have been agreed. In essence, ergotamine, from a medical perspective, is the drug of choice in a limited number of migraine sufferers who have infrequent or long duration headaches and are likely to comply with dosing restrictions. For most migraine sufferers requiring a specific anti-migraine treatment, a triptan is generally a better option from both an efficacy and side-effect perspective. [less ▲]

Detailed reference viewed: 21 (2 ULg)
See detailErhebung dialektgeographischer Daten per Internet: ein Atlasprojekt zur deutschen Alltagssprache
Möller, Robert ULg; Elspaß, Stephan

in Elspaß, Stephan; König, Werner (Eds.) Sprachgeographie digital. Die neue Generation der Sprachatlanten (2008)

Detailed reference viewed: 23 (0 ULg)
Full Text
Peer Reviewed
See detailÉric Benoît, Les Poésies de Mallarmé et Mallarmé et le Mystère du « Livre »
Durand, Pascal ULg

in Littératures Classiques (2000), 43(automne), 173-180

Detailed reference viewed: 30 (10 ULg)
Full Text
Peer Reviewed
See detailEricksonian hypnosis in tinnitus therapy.
Maudoux, Audrey ULg; Bonnet, Sophie ULg; Lhonneux-Ledoux, F. et al

in B-ENT (2007), 3 Suppl 7

OBJECTIVE: To evaluate the effect of Ericksonian therapy on tinnitus STUDY DESIGN: Non-randomised, prospective longitudinal study. SETTING: Tertiary referral centre. PATIENTS: A total of 49 patients ... [more ▼]

OBJECTIVE: To evaluate the effect of Ericksonian therapy on tinnitus STUDY DESIGN: Non-randomised, prospective longitudinal study. SETTING: Tertiary referral centre. PATIENTS: A total of 49 patients underwent hypnosis therapy. Fourteen patients failed to finish the therapy (drop-out rate: 35%). Of the 35 patients who completed the therapy, 20 were male and 15 female. The average age was 46.3 years (range 17-78). INTERVENTION: The treatment is based on the principles and approaches of Ericksonian hypnosis. The first session was mainly dedicated to the evaluation of the impact of tinnitus on the patient's life and to an explanation of hypnosis therapy. The next sessions were "learning sessions" based on relaxation and mental imaging. Exercises were first based on all senses other than hearing. Then they focused on hearing, teaching patients how to modulate sound intensity, and finally how to modulate tinnitus intensity. Patients also learnt self-hypnosis. MAIN OUTCOME MEASURE(S): To evaluate the effect of the treatment, tinnitus was assessed with the Tinnitus Handicap Inventory questionnaire before and after the therapy. Results: After 5 to 10 sessions (mean: 8.09 + -1.92) of Ericksonian hypnosis therapy, the 35 patients were capable of self-hypnosis with the aim of modulating their tinnitus, and the measured THI score fell for all patients. The global score improved significantly from 60:23 before EH therapy to 16.9 at discharge. Within the group, the initial score was distributed as follows: 0% slight, 14% mild, 31% moderate, 31% severe and 23% catastrophic. The t-test for dependent variables revealed significant improvements in all subgroups (p < or = 0.005). CONCLUSIONS: The results of this clinical trial demonstrate that Ericksonian hypnosis, in particular using self-hypnosis, is a promising technique for treating patients with tinnitus. [less ▲]

Detailed reference viewed: 18 (0 ULg)
Full Text
Peer Reviewed
See detailERK activation upon hypoxia: involvement in HIF-1 activation.
Minet, E.; Arnould, T.; Michel, G. et al

in FEBS Letters (2000), 468(1), 53-8

Hypoxia-inducible factor-1 (HIF-1) is a transcription factor activated by hypoxia. The HIF-1 activation transduction pathway is poorly understood. In this report, we investigated the activation of ... [more ▼]

Hypoxia-inducible factor-1 (HIF-1) is a transcription factor activated by hypoxia. The HIF-1 activation transduction pathway is poorly understood. In this report, we investigated the activation of extracellular regulated kinases (ERK) in hypoxia and their involvement in HIF-1 activation. We demonstrated that in human microvascular endothelial cells-1 (HMEC-1), ERK kinases are activated during hypoxia. Using dominant negative mutants, we showed that ERK1 is needed for hypoxia-induced HIF-1 transactivation activity. Moreover, using a kinase assay and Western blot experiments, we showed that HIF-1alpha is phosphorylated in hypoxia by an ERK-dependent pathway. These results evidence the role of mitogen-activated protein kinase in the transcriptional response to hypoxia. [less ▲]

Detailed reference viewed: 27 (3 ULg)
Full Text
Peer Reviewed
See detailERK and calcium in activation of HIF-1.
Mottet, Denis ULg; Michel, Gaetan; Renard, Patricia et al

in Annals of the New York Academy of Sciences (2002), 973

HIF-1 (hypoxia-inducible factor-1) is the main transcription factor responsible for increased gene expression in hypoxia. The oxygen-dependent regulation of HIF-1 activity occurs at multiple levels in ... [more ▼]

HIF-1 (hypoxia-inducible factor-1) is the main transcription factor responsible for increased gene expression in hypoxia. The oxygen-dependent regulation of HIF-1 activity occurs at multiple levels in vivo. The mechanisms regulating HIF-1alpha protein expression have been most extensively analyzed, but the ones modulating HIF-1 transcriptional activity remain unclear. Changes in the phosphorylation and/or redox status of HIF-1alpha certainly play a role. Here, we show that ionomycin could activate HIF-1 transcriptional activity in a way that is additive to the effect of hypoxia without affecting HIF-1alpha protein level and HIF-1 DNA binding capacity. In addition, a calmodulin dominant-negative mutant as well as BAPTA, an intracellular calcium chelator, inhibited the hypoxia-induced HIF-1 activation. These results indicate that elevated calcium in hypoxia could participate in HIF-1 activation. PD98059, an inhibitor of the ERK pathway, but not KN-93, an inhibitor of calmodulin kinases II and IV, also blocked HIF-1 activation by hypoxia and by ionomycin. Altogether, these results suggest that calcium and calmodulin would act upstream of ERK in the hypoxia signal transduction pathway leading to enhanced HIF-1 transcriptional activity. [less ▲]

Detailed reference viewed: 48 (2 ULg)
Full Text
Peer Reviewed
See detailERK2 activation in arteriolar and venular murine thrombosis: platelet receptor GPIb vs. P2X.
Oury, Cécile ULg; Daenens, Kim; Hu, Hu et al

in Journal of Thrombosis and Haemostasis [=JTH] (2006)

The functional significance of extracellular signal-regulated kinase 2 (ERK2) activation was investigated during shear induced human platelet aggregation (SIPA) in vitro and during shear controlled ... [more ▼]

The functional significance of extracellular signal-regulated kinase 2 (ERK2) activation was investigated during shear induced human platelet aggregation (SIPA) in vitro and during shear controlled thrombosis in vivo in intestinal arterioles and venules of wild type (WT) and transgenic (TG) mice with platelet-specific overexpression of human P2X(1) (TG). The conclusions are that P2X(1) and ERK2 both participate in shear stress controlled thrombosis, but ERK2 activation is initiated predominantly via GPIb-VWF interactions. [less ▲]

Detailed reference viewed: 9 (1 ULg)
Peer Reviewed
See detailErlebald (+ 1193), gardien des reliques de Stavelot-Malmedy
George, Philippe ULg

in Moyen Age (Le) (1984), XC

La personnalité d'Erlebald, frère de Wibald, pour la première fois mise en évidence dans le soin apporté aux reliques et aux oeuvres d'art de l'abbaye de Stavelot-Malmedy

Detailed reference viewed: 15 (5 ULg)
Full Text
Peer Reviewed
See detailErlotinib-responsive actinic keratoses.
Hermanns, Jean-Francois; Pierard, Gérald ULg; Quatresooz, Pascale ULg

in Oncology Reports (2007), 18(3), 581-4

Erlotinib is an inhibitor of the tyrosine-kinase domain of the epidermal growth factor receptor-1 (EGFR). This drug is used to treat some solid cancers, particularly advanced non-small-cell lung carcinoma ... [more ▼]

Erlotinib is an inhibitor of the tyrosine-kinase domain of the epidermal growth factor receptor-1 (EGFR). This drug is used to treat some solid cancers, particularly advanced non-small-cell lung carcinoma. Similar to other EGFR inhibitors, erlotinib is responsible for a series of skin adverse reactions, particularly acneiform lesions. We described the incidental effect of erlotinib on actinic keratoses which became markedly inflamed and showed partial regression. Inflammation appeared to spontaneously decrease while on erlotinib treatment. This reaction in the skin neoplasm is perhaps a visible and accessible model for predicting the effect in the deep-seated neoplasm targeted by the drug. [less ▲]

Detailed reference viewed: 41 (4 ULg)